Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1.
Saved in:
| Title: | Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1. |
|---|---|
| Authors: | Strand, Vibeke1 (AUTHOR), Mease, Philip J.2 (AUTHOR), Soriano, Enrique R.3 (AUTHOR), Kishimoto, Mitsumasa4 (AUTHOR), Salvarani, Carlo5 (AUTHOR), Saffore, Christopher D.6 (AUTHOR) christopher.saffore@abbvie.com, Zueger, Patrick6 (AUTHOR), McDearmon-Blondell, Erin6 (AUTHOR), Kato, Koji6 (AUTHOR), Gladman, Dafna D.7 (AUTHOR) |
| Source: | Rheumatology & Therapy. Dec2021, Vol. 8 Issue 4, p1789-1808. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!